About ChromaCode

ChromaCode is a leading provider of HDPCR (High-Definition Polymerase Chain Reaction) multiplexing technology for genomic solutions. The company's breakthrough platform enables labs, physicians, and patients to access advanced molecular diagnostics capabilities. ChromaCode's innovative bioinformatics technology helps address critical challenges in clinical diagnostics, including low sample input issues common with core biopsy specimens used in cancer diagnosis.

The Challenge

As a molecular diagnostics company developing clinical laboratory tests, ChromaCode faced the challenge of ensuring their HDPCR technology platform met stringent clinical laboratory regulations and data protection requirements. The company needed to demonstrate compliance with FDA and CLIA regulations while protecting sensitive patient genomic data and proprietary diagnostic algorithms.

Partner Solution

Jacobian Engineering worked with ChromaCode to implement comprehensive security and compliance controls specifically designed for molecular diagnostics platforms. The solution focused on protecting clinical laboratory data while enabling the high-performance computing required for genomic analysis.

Key implementation areas included:

• Clinical Laboratory Compliance: Implementation of CLIA and FDA regulatory requirements
• Genomic Data Security: Specialized protection for molecular diagnostic data and patient samples
• Bioinformatics Platform Security: Security controls for HDPCR technology and analytical algorithms
• Quality Management Systems: Secure systems supporting clinical laboratory quality standards
• Research and Development Security: Protection of proprietary diagnostic technologies and research data

Results and Benefits

The security and compliance implementation enabled ChromaCode to advance their molecular diagnostics platform while meeting regulatory requirements and protecting sensitive clinical data. The robust framework positioned the company for growth in the expanding precision medicine market.